| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 9 | 10 | 0 | 7 | -9 | 0 | 4 | 
| P | %wins | 100 | 100 | 100 | 100 | 0 | 80 | 
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/23/23 20:30 | 8/22/23 | ADMA | Adma Biologics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Fong Bryant | NJ | D | S | -5,545 | 3.87 | 0 | -1,433 | -96 | 60 | I | |||||||||||||||
| 8/31/16 18:43 | 8/31/16 | NEOS | Neos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fong Bryant | TX | D | P | 10 | 6.54 | 1 | 2 | New | 2 | D | -75 | -42 | -39 | -28 | -22 | -4 | -2 | 9 | 10 | 0 | 7 | -9 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |